FundedIQ
Biotechnology

Pictor

Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously – with higher sensitivity, faster throughput, and reduced turn-around time. The company’s lead product, PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to reduce the threat of COVID-19

www.pictordx.com Parnell, New Zealand 11-50 employees
Total raised
$17.5M
Latest round: +75% of prior total
Rounds
4
Latest
Series Unknown
Jun 2026

Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously – with higher sensitivity, faster throughput, and reduced turn-around time. The company’s lead product, PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to reduce the threat of COVID-19

Pictor has raised $17.5M across 4 rounds. Its most recent round was a Series Unknown of $7.5M in Jun 2026. Full funding history, investors, and team are detailed below.

Funding history

4 rounds · 1 visible Unlock with plan

4 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
Jun 30, 2026
Series Unknown
$7.5M

Unlock 3 earlier rounds — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Pictor is featured in

Similar companies

Pacific Edge

Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Their products are built from their proprietary genetic databases, which are used to identify diagnostic and prognostic biomarkers for cancer.

Series Unknown $15.1M
Scentian Bio

Scentian Bio functions as a platform that offers a comprehensive sensing solution.

Seed $7.0M
Algorae Pharmaceuticals

Algorae Pharmaceuticals is an Australasian biotechnology company working on AI-enhanced drug research and discovery initiatives to improve the health of individuals

Series Unknown $2.3M
Mars Bioimaging

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.

Series A $15.0M
Bontia Bio
Seed $720k
Alimetry

Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.

Series A $18.0M
Jooules

Jooules provides a sustainable food solution that promotes a more environmentally friendly and healthier future through the use of fermentation techniques to produce nutritious protein ingredients.

Pre-Seed $590k
Beeline Medicines

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

Series A $126M
Tenon Medical

Tenon Medical, a biotech firm specializing in enhancing surgical solutions for the SI joint, was established in 2012 in Morgan Hill, California.

Series Unknown $4.2M
Biodexa Pharmaceuticals

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a commercial platform and four marketed products in the US. Midatech's strategy is to develop products in-house in oncology and with partners in other indications, and to accelerate growth organically and through strategic acquisitions.

Series Unknown $3.5M
Collplant

CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Rehovot, Israel.

Series Unknown $2.6M
iPremom

iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.

Series Unknown $2.8M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.